General form of registration statement for all companies including face-amount certificate companies

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.21.2
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Total
Class A/B Shares
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2017   16,631,000        
Balance, amount at Dec. 31, 2017 $ (5,211,000)       $ 7,772,000 $ (12,982,000)
Net loss (8,711,000) $ 0 $ 0 $ 0 0 (8,711,000)
Shares issued in connection with conversion of convertible debentures, shares   1,947,000        
Shares issued in connection with conversion of convertible debentures, amount 3,961,000       3,961,000 0
Issuance of shares associated with acquisitions, shares   88,000        
Issuance of shares associated with acquisitions, amount 370,000       370,000 0
Issuance of Series B preferred stock, net of issuance costs, shares   9,831,000        
Issuance of Series B preferred stock, net of issuance costs, amount 41,873,000       41,873,000 0
Issuance of warrants in exchange for services, amount 87,000       87,000  
Share-based compensation expense, amount 270,000       270,000  
Balance, shares at Dec. 31, 2018   28,497,000        
Balance, amount at Dec. 31, 2018 32,640,000       54,333,000 (21,693,000)
Net loss (49,934,000) $ 0 $ 0 $ 0 0 (49,934,000)
Share-based compensation expense, amount 3,385,000       3,385,000 0
Adoption of lease accounting standard, amount (847,000)         (847,000)
Issuance of subordinate voting shares in exchange for Class A/B shares, net, shares   (28,497,000) 28,497,000      
Issuance of subordinate voting shares in exchange for Class A/B shares, net, amount 0       0 0
Private placement in connection with reverse takeover, net, shares     3,433,000      
Private placement in connection with reverse takeover, net, amount 36,762,000       36,762,000 0
Shares issued to acquiree in connection with reverse takeover, shares     130,000      
Shares issued to acquiree in connection with reverse takeover, amount 1,513,000       1,513,000 0
Issuance of supervoting shares, shares       203,000    
Issuance of supervoting shares, amount 40,000       40,000 0
Exercise of options, shares     125,000      
Exercise of options, amount 127,000       127,000 0
Share-based compensation expense, shares     659,000      
Issuance of warrants 2,291,000          
Balance, shares at Dec. 31, 2019     32,844,000 203,000    
Balance, amount at Dec. 31, 2019 23,686,000       96,160,000 (72,474,000)
Net loss (16,631,000)   $ 0 $ 0 0 (16,631,000)
Shares issued in connection with conversion of convertible debentures, shares     250,000      
Shares issued in connection with conversion of convertible debentures, amount 62,000     0 62,000 0
Share-based compensation expense, amount 1,825,000     0 1,825,000 0
Share-based compensation expense, shares     248,000      
Issuance of warrants 1,556,000   $ 0 $ 0 1,556,000 0
Balance, shares at Jun. 30, 2020     33,342,000 203,000    
Balance, amount at Jun. 30, 2020 10,498,000       99,603,000 (89,105,000)
Balance, shares at Dec. 31, 2019     32,844,000 203,000    
Balance, amount at Dec. 31, 2019 23,686,000       96,160,000 (72,474,000)
Net loss (21,910,000)         (21,910,000)
Shares issued in connection with conversion of convertible debentures, shares     375,000      
Shares issued in connection with conversion of convertible debentures, amount 75,000       75,000 0
Issuance of shares associated with acquisitions, shares     150,000      
Issuance of shares associated with acquisitions, amount 179,000       179,000  
Share-based compensation expense, amount $ 2,200,000       2,200,000 0
Exercise of options, shares 0          
Share-based compensation expense, shares     248,000      
Issuance of warrants $ 1,620,000          
Issuance of stock warrants, amount 1,556,000       1,556,000 0
Shares issued in connection with convertible debenture offering, shares     250,000      
Shares issued in connection with convertible debenture offering, amount 62,000       62,000 0
Shares issued in connection with subordinate voting share offering, shares     23,000,000      
Shares issued in connection with subordinate voting share offering, amount 25,021,000       25,021,000 0
Issuance of stock options associated with acquisitions, amount 116,000       116,000 0
Reduction in supervoting share purchase price, amount (39,000)       (39,000) 0
Exercise of warrants, shares     750,000      
Exercise of warrants, amount 210,000       210,000 0
Balance, shares at Dec. 31, 2020     57,617,000 203,000    
Balance, amount at Dec. 31, 2020 31,156,000       125,540,000 (94,384,000)
Balance, shares at Mar. 31, 2020     32,988,000 203,000    
Balance, amount at Mar. 31, 2020 17,424,000       97,772,000 (80,348,000)
Net loss (8,757,000)   $ 0 $ 0 0 (8,757,000)
Shares issued in connection with conversion of convertible debentures, shares     250,000      
Shares issued in connection with conversion of convertible debentures, amount 62,000     0 62,000 0
Share-based compensation expense, amount 213,000     0 213,000 0
Share-based compensation expense, shares     104,000      
Issuance of warrants 1,556,000   $ 0 $ 0 1,556,000 0
Balance, shares at Jun. 30, 2020     33,342,000 203,000    
Balance, amount at Jun. 30, 2020 10,498,000       99,603,000 (89,105,000)
Balance, shares at Dec. 31, 2020     57,617,000 203,000    
Balance, amount at Dec. 31, 2020 31,156,000       125,540,000 (94,384,000)
Net loss (5,988,000)   $ 0 $ 0 0 (5,988,000)
Shares issued in connection with conversion of convertible debentures, shares     2,393,000      
Shares issued in connection with conversion of convertible debentures, amount 478,000       478,000 0
Issuance of shares associated with acquisitions, shares     30,641,000      
Issuance of shares associated with acquisitions, amount 43,259,000     0 43,259,000 0
Share-based compensation expense, amount $ 625,000       625,000 0
Exercise of options, shares 0   76,000      
Exercise of options, amount $ 46,000       46,000  
Share-based compensation expense, shares     371,000      
Issuance of warrants 0          
Exercise of warrants, shares     1,325,000      
Exercise of warrants, amount 665,000     $ 0 665,000  
Balance, shares at Jun. 30, 2021     92,423,000 203,000    
Balance, amount at Jun. 30, 2021 70,241,000       170,613,000 (100,372,000)
Balance, shares at Mar. 31, 2021     83,221,000 203,000    
Balance, amount at Mar. 31, 2021 59,903,000       161,006,000 (101,103,000)
Net loss 731,000   $ 0 $ 0 0 731,000
Shares issued in connection with conversion of convertible debentures, shares     1,003,000      
Shares issued in connection with conversion of convertible debentures, amount 200,000   $ 0   200,000 0
Issuance of shares associated with acquisitions, shares     7,998,000      
Issuance of shares associated with acquisitions, amount 9,023,000     0 9,023,000 0
Share-based compensation expense, amount 338,000     0 338,000 0
Exercise of options, shares     76,000      
Exercise of options, amount 46,000     $ 0 46,000 0
Share-based compensation expense, shares     125,000      
Balance, shares at Jun. 30, 2021     92,423,000 203,000    
Balance, amount at Jun. 30, 2021 $ 70,241,000       $ 170,613,000 $ (100,372,000)